英特格拉生命科学(IART)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IART 英特格拉生命科学

盘后交易 11-11 16:03:59 EST

14.77

+0.24

+1.65%

盘后14.77

+0.000.00%

16:00 EST

最高15.07	最低14.37	成交量99.94万
今开14.55	昨收14.53	日振幅4.82%
总市值11.50亿	流通市值8.67亿	总股本7,789万
成交额1,475万	换手率1.70%	流通股本5,867万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"IART","market":"US","secType":"STK","nameCN":"英特格拉生命科学","latestPrice":14.77,"timestamp":1794430800000,"preClose":14.53,"halted":0,"volume":999420,"hourTrading":{"tag":"盘后","latestPrice":14.77,"preClose":14.77,"latestTime":"16:00 EST","volume":14974,"amount":221165.97999999998,"timestamp":1794430857835,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.016517549896765328,"floatShares":58672000,"shares":77892111,"eps":0.167934,"marketStatus":"盘后交易","change":0.24,"latestTime":"11-11 16:03:59 EST","open":14.55,"high":15.07,"low":14.37,"amount":14751481,"amplitude":0.048176,"askPrice":15.1,"askSize":40,"bidPrice":14.35,"bidSize":104,"shortable":3,"etf":0,"ttmEps":0.167934,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1794445200000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":14.53,"preHourTrading":{"tag":"盘前","latestPrice":14.46,"preClose":14.53,"latestTime":"09:26 EST","volume":2286,"amount":33353.878428,"timestamp":1794407201745,"change":-0.07,"changeRate":-0.004818,"amplitude":0.240881},"postHourTrading":{"tag":"盘后","latestPrice":14.77,"preClose":14.77,"latestTime":"16:00 EST","volume":14974,"amount":221165.97999999998,"timestamp":1794430857835,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.854971,"impliedVol":0.5684,"impliedVolPercentile":0.4024},"requestUrl":"/m/hq/s/IART/tweets","defaultTab":"tweets","newsList":[{"id":"1117223638","title":"财报前瞻 | 英特格拉生命科学本季度营收或持平微增，机构观点偏谨慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1117223638","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117223638?lang=zh_cn&edition=full","pubTime":"2026-10-14 10:08","pubTimestamp":1791943724,"startTime":"0","endTime":"0","summary":"英特格拉生命科学将于2025年10月21日发布最新季度财报，市场关注收入改善与利润率修复节奏。市场一致预期本季度公司营收约为4.15亿美元，同比增长0.28%；调整后每股收益约为0.56美元，同比预计增长29.26%；息税前利润约为7,155.19万美元，同比预计增长25.20%；未见针对本季度毛利率与净利率的明确一致预期。上季度公司营收4.19亿美元，同比增长0.76%；毛利率55.80%；归属于母公司股东的净利润448.20万美元，净利率1.07%，环比增长197.08%；调整后每股收益0.56美元，同比增长24.44%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻 | 英特格拉生命科学本季度营收或持平微增，机构观点偏谨慎","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IART"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115319601","title":"英特格拉生命科学重申2026年有机营收增长及调整后每股收益指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1115319601","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115319601?lang=zh_cn&edition=full","pubTime":"2026-07-29 18:06","pubTimestamp":1785319607,"startTime":"0","endTime":"0","summary":"英特格拉生命科学——这家医疗科技公司再度确认其2026年度的业绩预期。该公司预计，有机营收将实现0.8%至3.3%的同比增长。与此同时，其调整后的每股收益（Adj EPS）目标区间也被锁定在2.40美元至2.50美元之间。这一最新的财务指引，彰显了管理层对业务前景的审慎乐观态度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IART","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141245739","title":"花旗将英特格拉生命科学评级上调至中性，目标价调高至16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1141245739","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1141245739?lang=zh_cn&edition=full","pubTime":"2026-05-29 18:26","pubTimestamp":1780050372,"startTime":"0","endTime":"0","summary":"花旗集团调整了对英特格拉生命科学控股公司的股票评级，将其从“卖出”上调至“中性”。与此同时，该行将其目标股价从11美元大幅调升至16美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IART","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516376059","title":"英特格拉生命科学2024财年实现净利润-6.94百万美元，同比减少110.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516376059","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516376059?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:00","pubTimestamp":1740758456,"startTime":"0","endTime":"0","summary":"3月1日，英特格拉生命科学公布财报，公告显示公司2024财年净利润为-6.94百万美元，同比减少110.25%；其中营业收入为16.11亿美元，同比增加4.47%，每股基本收益为-0.09美元。从资产负债表来看，英特格拉生命科学总负债24.92亿美元，其中短期债务6.22亿美元，资产负债比为1.62，流动比率为1.18。机构评级：截至2025年3月1日，当前有8家机构对英特格拉生命科学目标价做出预测，其中目标均价为26.25美元，其中最低目标价为20.00美元，最高目标价为35.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301000146a2581846&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301000146a2581846&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IART"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514859090","title":"英特格拉生命科学盘中异动 早盘股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514859090","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514859090?lang=zh_cn&edition=full","pubTime":"2025-02-26 23:05","pubTimestamp":1740582308,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日23时05分，英特格拉生命科学股票出现波动，股价急速下跌5.02%。截至发稿，该股报23.48美元/股，成交量7.7221万股，换手率0.10%，振幅5.54%。英特格拉生命科学股票所在的医疗器械行业中，整体涨幅为0.62%。英特格拉生命科学公司简介：Integra Lifesciences Holdings Corp 是一家总部位于新泽西州的医疗设备公司，专注于开发用于再生疗法、肢体骨科和神经外科应用的产品。Codman 专业外科部门从其细分业务中获得最大收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226230509abddf4fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226230509abddf4fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IART","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186156552","title":"异动解读 | 英特格拉生命科学公司第四季度业绩好于预期,盘中股价大涨5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=1186156552","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1186156552?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:55","pubTimestamp":1740495312,"startTime":"0","endTime":"0","summary":"英特格拉生命科学公司(IART)今日盘中股价大涨5.44%,引发市场广泛关注。\n\n公司发布的最新季度财报显示,第四季度调整后每股收益为0.97美元,高于分析师预期的0.86美元。营收同比增长11.5%,达到4.4265亿美元,但仍略低于分析师预期的4.4515亿美元。\n\n由于业绩好于市场预期,尤其是调整后每股收益超出预期,这提振了投资者对公司的信心,推动股价在盘中大幅上涨。虽然营收数据略逊预期,但公司销售增长态势良好,这也是导致股价上涨的重要原因之一。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["IART"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514180310","title":"英特格拉生命科学盘中异动 早盘股价大涨5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514180310","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514180310?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:49","pubTimestamp":1740494947,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时49分，英特格拉生命科学股票出现异动，股价快速拉升5.44%。截至发稿，该股报23.25美元/股，成交量8.4322万股，换手率0.11%，振幅9.02%。英特格拉生命科学股票所在的医疗器械行业中，整体跌幅为0.44%。英特格拉生命科学公司简介：Integra Lifesciences Holdings Corp 是一家总部位于新泽西州的医疗设备公司，专注于开发用于再生疗法、肢体骨科和神经外科应用的产品。Codman 专业外科部门从其细分业务中获得最大收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224907a2538b6b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224907a2538b6b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","IART"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102458597","title":"异动解读 | 财报营收不佳、业绩预期下调 英特格拉生命科学盘前重挫5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=1102458597","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1102458597?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:30","pubTimestamp":1740493821,"startTime":"0","endTime":"0","summary":"英特格拉生命科学今日盘前股价大跌5.44%,引发市场关注。首先,公司公布的第四季度营收4.426亿美元,低于分析师预期的4.451亿美元,财报营收数据不佳令投资者失望。虽然公司第四季度利润超出预期,但营收不佳引发了市场对其业绩的担忧。再者,该股在过去12个月内下跌了50.7%,股价持续下跌期间任何不利消息都可能引发投资者进一步抛售。因此,公司业绩数据不佳和下调业绩预期,引发了投资者本轮抛售情绪。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["IART"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152244544","title":"Integra Lifesciences第四季度调整后每股收益$0.97超出预期$0.86，销售额$4.4264亿低于预期$4.4515亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1152244544","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1152244544?lang=zh_cn&edition=full","pubTime":"2025-02-25 19:08","pubTimestamp":1740481724,"startTime":"0","endTime":"0","summary":"Integra Lifesciences  公布季度每股收益为$0.97，高于分析师普遍预期的$0.86，增幅达到12.79%。相比去年同期每股收益$0.89，本次业绩增长了8.99%。公司季度销售额为$4.4264亿，未能达到分析师预期的$4.4515亿，差距为0.56%。以上内容来自Benzinga Earnings专栏，原文如下：Integra Lifesciences  reported quarterly earnings of $0.97 per share which beat the analyst consensus estimate of $0.86 by 12.79 percent. This is a 8.99 percent increase over earnings of $0.89 per share from the same period last year. The company reported quarterly sales of $442.64 million which missed the analyst consensus estim","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Integra Lifesciences第四季度调整后每股收益$0.97超出预期$0.86，销售额$4.4264亿低于预期$4.4515亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IART"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514772083","title":"英特格拉生命科学盘中异动 下午盘快速拉升5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514772083","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514772083?lang=zh_cn&edition=full","pubTime":"2025-02-25 02:30","pubTimestamp":1740421840,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日02时30分，英特格拉生命科学股票出现波动，股价急速上涨5.02%。截至发稿，该股报22.19美元/股，成交量56.2995万股，换手率0.73%，振幅4.31%。英特格拉生命科学股票所在的医疗器械行业中，整体涨幅为0.85%。英特格拉生命科学公司简介：Integra Lifesciences Holdings Corp 是一家总部位于新泽西州的医疗设备公司，专注于开发用于再生疗法、肢体骨科和神经外科应用的产品。Codman 专业外科部门从其细分业务中获得最大收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225023041abdb4240&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225023041abdb4240&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","IART"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511302586","title":"英特格拉生命科学盘中异动 股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511302586","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511302586?lang=zh_cn&edition=full","pubTime":"2025-02-13 00:33","pubTimestamp":1739377997,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日00时33分，英特格拉生命科学股票出现波动，股价快速下跌5.10%。截至发稿，该股报24.37美元/股，成交量5.6238万股，换手率0.07%，振幅3.93%。英特格拉生命科学股票所在的医疗器械行业中，整体跌幅为0.88%。英特格拉生命科学公司简介：Integra Lifesciences Holdings Corp 是一家总部位于新泽西州的医疗设备公司，专注于开发用于再生疗法、肢体骨科和神经外科应用的产品。Codman 专业外科部门从其细分业务中获得最大收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213003318a2436e9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213003318a2436e9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IART","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505878151","title":"英特格拉生命科学盘中异动 股价大涨5.02%报25.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505878151","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505878151?lang=zh_cn&edition=full","pubTime":"2025-01-22 04:45","pubTimestamp":1737492316,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日04时45分，英特格拉生命科学股票出现波动，股价快速上涨5.02%。截至发稿，该股报25.31美元/股，成交量45.1258万股，换手率0.58%，振幅4.42%。机构评级方面，在所有13家参与评级的机构中，15%的券商给予买入建议，54%的券商给予持有建议，31%的券商给予卖出建议。英特格拉生命科学股票所在的医疗器械行业中，整体涨幅为2.32%。Codman 专业外科部门从其细分业务中获得最大收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122044516960bf7c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122044516960bf7c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IART","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501517092","title":"英特格拉生命科学盘中异动 早盘股价大跌5.03%报22.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501517092","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501517092?lang=zh_cn&edition=full","pubTime":"2025-01-07 00:01","pubTimestamp":1736179290,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日00时01分，英特格拉生命科学股票出现异动，股价急速下挫5.03%。截至发稿，该股报22.01美元/股，成交量15.5985万股，换手率0.20%，振幅6.00%。机构评级方面，在所有13家参与评级的机构中，15%的券商给予买入建议，54%的券商给予持有建议，31%的券商给予卖出建议。英特格拉生命科学股票所在的医疗器械行业中，整体涨幅为0.38%。Codman 专业外科部门从其细分业务中获得最大收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107000130a217ab42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107000130a217ab42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","IART"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2483851528","title":"英特格拉生命科学盘中异动 下午盘大幅下挫5.00%报23.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483851528","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2483851528?lang=zh_cn&edition=full","pubTime":"2024-11-14 03:37","pubTimestamp":1731526635,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日03时37分，英特格拉生命科学股票出现异动，股价急速下挫5.00%。截至发稿，该股报23.57美元/股，成交量76.8216万股，换手率1.00%，振幅5.08%。机构评级方面，在所有14家参与评级的机构中，21%的券商给予买入建议，50%的券商给予持有建议，29%的券商给予卖出建议。英特格拉生命科学股票所在的医疗器械行业中，整体跌幅为0.27%。Codman 专业外科部门从其细分业务中获得最大收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114033715abbe7447&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114033715abbe7447&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","IART"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152196541","title":"异动解读 | 英特格拉生命科学盘中大涨 医疗设备股表现向好","url":"https://stock-news.laohu8.com/highlight/detail?id=1152196541","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1152196541?lang=zh_cn&edition=full","pubTime":"2024-11-12 01:46","pubTimestamp":1731347205,"startTime":"0","endTime":"0","summary":"2024年11月12日,医疗设备公司英特格拉生命科学盘中股价大涨5.49%,最高触及26.26美元。这一走势引起了市场广泛关注。英特格拉生命科学是一家总部位于新泽西州的医疗器械公司,主要从事再生疗法、肢体骨科和神经外科产品的开发和生产。其中医疗器械板块收入占比最高。但目前尚未见到公司发布的直接相关重大利好消息。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 英特格拉生命科学盘中大涨 医疗设备股表现向好","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["IART"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2482753101","title":"英特格拉生命科学盘中异动 股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482753101","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2482753101?lang=zh_cn&edition=full","pubTime":"2024-11-12 01:32","pubTimestamp":1731346351,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日01时32分，英特格拉生命科学股票出现波动，股价大幅拉升5.08%。截至发稿，该股报26.04美元/股，成交量14.0535万股，换手率0.18%，振幅4.52%。英特格拉生命科学股票所在的医疗器械行业中，整体涨幅为0.83%。英特格拉生命科学公司简介：Integra Lifesciences Holdings Corp 是一家总部位于新泽西州的医疗设备公司，专注于开发用于再生疗法、肢体骨科和神经外科应用的产品。Codman 专业外科部门从其细分业务中获得最大收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112013231abb6b9ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112013231abb6b9ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","IART"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2482742211","title":"英特格拉生命科学2024财年第三财季实现净利润-10.70百万美元，同比减少154.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482742211","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2482742211?lang=zh_cn&edition=full","pubTime":"2024-11-10 00:02","pubTimestamp":1731168135,"startTime":"0","endTime":"0","summary":"11月10日，英特格拉生命科学公布财报，公告显示公司2024财年第三财季净利润为-10.70百万美元，同比减少154.87%；其中营业收入为3.81亿美元，同比减少0.26%，每股基本收益为-0.14美元。从资产负债表来看，英特格拉生命科学总负债25.44亿美元，其中短期债务6.17亿美元，资产负债比为1.60，流动比率为1.21。机构评级：截至2024年11月10日，当前有8家机构对英特格拉生命科学目标价做出预测，其中目标均价为28.62美元，其中最低目标价为21.00美元，最高目标价为40.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000241abb100b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000241abb100b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IART"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2481545130","title":"英特格拉生命科学盘中异动 下午盘股价大跌5.09%报25.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481545130","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2481545130?lang=zh_cn&edition=full","pubTime":"2024-11-08 03:00","pubTimestamp":1731006020,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日03时00分，英特格拉生命科学股票出现异动，股价大幅下跌5.09%。截至发稿，该股报25.34美元/股，成交量35.743万股，换手率0.46%，振幅4.48%。机构评级方面，在所有13家参与评级的机构中，23%的券商给予买入建议，54%的券商给予持有建议，23%的券商给予卖出建议。英特格拉生命科学股票所在的医疗器械行业中，整体跌幅为0.61%。Codman 专业外科部门从其细分业务中获得最大收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110803002098e4145a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110803002098e4145a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IART","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2481366985","title":"英特格拉生命科学盘中异动 股价大涨5.02%报26.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481366985","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2481366985?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:31","pubTimestamp":1730903507,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时31分，英特格拉生命科学股票出现波动，股价大幅拉升5.02%。截至发稿，该股报26.16美元/股，成交量2.6923万股，换手率0.03%，振幅2.25%。机构评级方面，在所有13家参与评级的机构中，23%的券商给予买入建议，54%的券商给予持有建议，23%的券商给予卖出建议。英特格拉生命科学股票所在的医疗器械行业中，整体涨幅为1.59%。Codman 专业外科部门从其细分业务中获得最大收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223147aba6afe0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223147aba6afe0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IART","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2480058136","title":"英特格拉生命科学股价飙升14.11% 市值涨2.41亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480058136","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2480058136?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:31","pubTimestamp":1730730684,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时31分，英特格拉生命科学股票出现异动，股价快速上涨14.11%。英特格拉生命科学股票所在的医疗器械行业中，整体涨幅为0.29%。其相关个股中，Nuwellis, Inc.、Profound Medical Corp.、英特格拉生命科学涨幅较大，Nuwellis, Inc.、Tenon Medical, Inc.、Catheter Precision, Inc.较为活跃，换手率分别为556.59%、6.62%、1.46%，振幅较大的相关个股有英特格拉生命科学、Nuwellis, Inc.、Pacific Biosciences Of California, Inc.，振幅分别为11.94%、8.09%、4.51%。Codman 专业外科部门从其细分业务中获得最大收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422312495bdc99e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422312495bdc99e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IART","BK4082"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.integralife.com;investor.integralife.com","stockEarnings":[{"period":"1week","weight":0.066},{"period":"1month","weight":0.0811},{"period":"3month","weight":-0.164},{"period":"6month","weight":0.0021},{"period":"1year","weight":0.1929},{"period":"ytd","weight":0.1699}],"compareEarnings":[{"period":"1week","weight":-0.0059},{"period":"1month","weight":-0.0368},{"period":"3month","weight":-0.0292},{"period":"6month","weight":0.0023},{"period":"1year","weight":0.1005},{"period":"ytd","weight":0.0997}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Integra Lifesciences Holdings Corporation于1989年在特拉华州注册成立，是一家全球领先的医疗技术公司，通过创新治疗途径来提高患者的预后，并制定外科、神经系统和再生护理的新标准。公司通过全球收购和产品开发，将基地再生技术业务扩展至包括手术器械、神经外科产品和先进的伤口护理，以满足客户不断变化的需求并增强患者护理。","yearOnYearQuotes":[{"month":1,"riseRate":0.612903,"avgChangeRate":0.066907},{"month":2,"riseRate":0.516129,"avgChangeRate":0.02882},{"month":3,"riseRate":0.451613,"avgChangeRate":-0.017214},{"month":4,"riseRate":0.580645,"avgChangeRate":0.007692},{"month":5,"riseRate":0.483871,"avgChangeRate":-0.007774},{"month":6,"riseRate":0.580645,"avgChangeRate":0.034585},{"month":7,"riseRate":0.612903,"avgChangeRate":0.015886},{"month":8,"riseRate":0.483871,"avgChangeRate":-0.018005},{"month":9,"riseRate":0.4375,"avgChangeRate":-0.000323},{"month":10,"riseRate":0.28125,"avgChangeRate":-0.036338},{"month":11,"riseRate":0.71875,"avgChangeRate":0.043461},{"month":12,"riseRate":0.548387,"avgChangeRate":0.010645}],"exchange":"NASDAQ","name":"英特格拉生命科学","nameEN":"Integra Lifesciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"英特格拉生命科学(IART)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供英特格拉生命科学(IART)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"英特格拉生命科学,IART,英特格拉生命科学股票,英特格拉生命科学股票老虎,英特格拉生命科学股票老虎国际,英特格拉生命科学行情,英特格拉生命科学股票行情,英特格拉生命科学股价,英特格拉生命科学股市,英特格拉生命科学股票价格,英特格拉生命科学股票交易,英特格拉生命科学股票购买,英特格拉生命科学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"英特格拉生命科学(IART)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供英特格拉生命科学(IART)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}